Fibroblastic galectin-1-fostered invasion and metastasis are mediated by TGF-β1-induced epithelial-mesenchymal transition in gastric cancer

Abstract

Background The gastric cancer (GC) microenvironment has important effects on biological behaviors, such as tumor cell invasion and metastasis. However, the mechanism by which the GC microenvironment promotes GC cell invasion and metastasis is unknown. The present study aimed to clarify the effects and mechanism of galectin-1 (GAL-1, encoded by LGALS1 ) on GC invasion and metastasis in the GC microenvironment. Methods The expression of GAL-1/ LGALS1 was determined using western blotting, immunohistochemistry, and quantitative real-time reverse transcription PCR in GC tissues. Besides, methods including stable transfection, Matrigel invasion and migration assays, and wound-healing assays in vitro ; and metastasis assays in vivo , were also conducted. Results GAL-1 from cancer-associated fibroblasts (CAFs) induced the epithelial-mesenchymal transition (EMT) of GC cells though the transforming growth factor beta (TGF-β1)/ Sma- and mad-related protein (Smad) pathway, and affected the prognosis of patients with GC. The level of GAL-1 was high in CAFs, and treating MGC-803 and SGC -7901 cell line with the conditioned medium from CAFs promoted their invasion and metastasis abilities. Overexpression of LGALS1 promoted the expression of TGF-β1 and induced EMT of GC cell lines. A TGF-β1 antagonist inhibited the invasion and migration of GC cells. In vivo , overexpression of LGALS1 promoted GC growth and metastasis, and the TGF-β1 antagonist dramatically reversed these events. Conclusions These findings suggested that high expression of GAL-1 in the GC microenvironment predicts a poor prognosis in patients with GC by promoting the migration and invasion of GC cells via EMT through the TGF-β1/Smad signaling pathway. The results might provide new therapeutic targets to treat GC.

Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies

“…To give just a few of the numerous breakthroughs, CAFs were shown to highly express lysyl oxidase, leading to an increase in matrix stiffness, promoting the EMT process in squamous cell carcinoma cells through the focal adhesion kinase phosphorylation pathway . The poor prognosis of patients with gastric cancer was explained by a high expression of galectin-1 in the microenvironment, produced by CAFs, promoting invasion of cancer cells via EMT through the TGF-β1/Smad signaling pathway (You et al, 2021). A new mechanism was elucidated for the acquisition of an invasive phenotype of non-neoplastic breast cells, induced by CAFs, involving interleukin 8 (IL-8) and S100A8 (Lim et al, 2021).…”

Galectin Family Members: Emerging Novel Targets for Lymphoma Therapy?

“…Overexpression of galectin-1 activates oncogenes, promotes the transformation of normal cells into malignant cells, and accelerates the growth and development of tumors by regulating the cell cycle ( 91 ). Galectin-1 promotes tumor migration, invasion, and angiogenesis through epithelial-mesenchymal transition ( 92 ), mediates the adhesion of tumor cells, and enhances the adhesion of cells to the extracellular matrix through glycoproteins in the basement membrane ( 93 ). Galectin-1 also accelerates the growth of tumor cells by promoting angiogenesis and the activation and proliferation of vascular endothelial cells ( 94 ).…”

Possible important roles of galectins in the healing of human fetal membranes

“…Activation of TGF-β by galectin-3 induces EMT in lung cancer A549 cells ( 52 ). In fibroblasts, galectin-1 induced EMT through the TGF-β1/Smad signaling pathway thereby promoting invasion and metastasis of gastric cancer cells ( 53 ). Galectin-1 induces epithelial mesenchymal transition (EMT) in human ovarian cancer cells through activation of the MAPK JNK/p38 signaling pathway ( 54 ).…”